Male breast cancer: are there racial disparities in incidence and tumor characteristics?
Main Article Content
Background: Racial disparities in female breast cancer (BC) outcomes have been well documented; however, less is known about patterns of BC and outcome disparities in men.
Methods: Data (1973 to 2012) from the Surveillance, Epidemiology, and End Results Program database were used to compare BC patterns among Non-Hispanic Black (NHB) and Non-Hispanic White (NHW) men and women. Differences in tumor characteristics analyzed included estrogen receptor (ER), progesterone receptor (PR) status, stage and grade.
Results: BC incidence was 1.00 per 100,000 for men and 116.21 for females. Among men, the BC incidence was 51% higher for NHB compared to NHW (rate ratio = 1.51, 95% CI: 1.42 – 1.61). Men were diagnosed an average of 5 years later than women; however NHB men (average age at diagnosis 63 years) overall were diagnosed 4 years earlier than NHW men (average age at diagnosis 67 years). NHB men showed a higher proportion of ER negative tumors compared to NHW men. As compared to NHW men, the odds of NHB men developing ER- BC was 1.67 (95% CI [1.21 – 2.31]) and 1.84 for ERPR- (95% CI [1.28 – 2.67]).
Conclusion: As observed among NHB women, NHB men are more likely to be diagnosed with more advanced disease features and also experience a higher proportion of hormone negative BC compared to NHW men.
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.